Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.23 is 74% above its 5-year average of -0.88, near the high end of its 5-year range (-2.54–0.32).
61.34% above its 12-month average of -0.59.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.23
EARNINGS PER SHARE (EPS) AVG TTM
-0.59
EARNINGS PER SHARE (EPS) AVG 3Y
-0.77
EARNINGS PER SHARE (EPS) AVG 5Y
-0.88
EARNINGS PER SHARE (EPS) AVG 10Y
-2.13
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+61.34%
CURRENT VS 3Y AVG
+70.23%
CURRENT VS 5Y AVG
+74.01%
CURRENT VS 10Y AVG
+89.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Journey Medical Corporation
Market Cap
$177.66M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.59
3Y Avg
-0.77
5Y Avg
-0.88
Market Cap
$175.06M
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.39
3Y Avg
-0.36
5Y Avg
-0.55
Market Cap
$173.99M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
Market Cap
$173.23M
Earnings Per Share (EPS)
-0.46
TTM Avg
-0.40
3Y Avg
-0.54
5Y Avg
-0.73
Market Cap
$182.12M
Earnings Per Share (EPS)
4.11
TTM Avg
0.53
3Y Avg
0.05
5Y Avg
-0.11
Market Cap
$173.18M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$171.35M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
Market Cap
$170.98M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$184.71M
Earnings Per Share (EPS)
-1.57
TTM Avg
-5.27
3Y Avg
-99.59
5Y Avg
-93.21
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $177.66M | -0.23 | -0.59 | -0.77 | -0.88 |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.06M | -0.41 | -0.39 | -0.36 | -0.55 |
| Precision BioSciences, Inc. (DTIL)vs › | $173.99M | -2.80 | -1.25 | -14.14 | -22.50 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -0.46 | -0.40 | -0.54 | -0.73 |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | 4.11 | 0.53 | 0.05 | -0.11 |
| Cue Biopharma, Inc. (CUE)vs › | $173.18M | -27.00 | -15.00 | -27.00 | -32.85 |
| Nkarta, Inc. (NKTX)vs › | $171.35M | -1.57 | -1.50 | -2.00 | -2.13 |
| MediWound Ltd. (MDWD)vs › | $170.98M | -1.60 | -2.56 | -2.45 | -2.61 |
| Canton Strategic Holdings Inc (CNTN)vs › | $184.71M | -1.57 | -5.27 | -99.59 | -93.21 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.76M | -1.07 | -1.44 | -2.10 | -1.78 |
Trailing EPS (TTM)
$-0.23
Forward EPS (Est.)
$-0.04
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.47 |
| 2024-12-31 | -0.72 |
| 2023-12-31 | -0.21 |
| 2022-12-31 | -1.69 |
| 2021-12-31 | -2.54 |
| 2020-12-31 | 0.32 |
| 2019-12-31 | 0.22 |
| 2018-12-31 | -5.27 |
| 2017-12-31 | -7.48 |
| 2016-12-31 | -2.70 |
| 2015-12-31 | -2.93 |
| 2014-12-31 | -1.29 |
